avapro has been researched along with Complication, Postoperative in 2 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
El-Haddad, MA | 1 |
Zalawadiya, SK | 1 |
Awdallah, H | 1 |
Sabet, S | 1 |
El-Haddad, HA | 1 |
Mostafa, A | 1 |
Rashed, A | 1 |
El-Naggar, W | 1 |
Farag, N | 1 |
Saleb, MA | 1 |
Jacob, S | 1 |
Coleman, CI | 1 |
Makanji, S | 1 |
Kluger, J | 1 |
White, CM | 1 |
1 trial available for avapro and Complication, Postoperative
Article | Year |
---|---|
Role of irbesartan in prevention of post-coronary artery bypass graft atrial fibrillation.
Topics: Age Factors; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Biphenyl Compounds; Coron | 2011 |
1 other study available for avapro and Complication, Postoperative
Article | Year |
---|---|
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhi | 2007 |